{"id":"https://openalex.org/W2139353173","doi":"https://doi.org/10.1124/mol.52.2.323","title":"Quantitative Structure-Activity Relationship of Multidrug Resistance Reversal Agents","display_name":"Quantitative Structure-Activity Relationship of Multidrug Resistance Reversal Agents","alternate_titles":[],"publication_year":1997,"publication_date":"1997-08-01","ids":{"openalex":"https://openalex.org/W2139353173","doi":"https://doi.org/10.1124/mol.52.2.323","mag":"2139353173","pmid":"https://pubmed.ncbi.nlm.nih.gov/9271356"},"language":"en","primary_location":{"id":"doi:10.1124/mol.52.2.323","doi":"https://doi.org/10.1124/mol.52.2.323","is_oa":false,"landing_page_url":"https://doi.org/10.1124/mol.52.2.323","pdf_url":null,"source":{"id":"https://openalex.org/S62949411","display_name":"Molecular Pharmacology","issn_l":"0026-895X","issn":["0026-895X","1521-0111"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2139353173"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109951465","display_name":"Gilles Klopman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147586","display_name":"Texas Children's Hospital","ror":"https://ror.org/05cz92x43","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210147586"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gilles Klopman","raw_affiliation_strings":["Department of Chemistry, Case Western Reserve University, Cleveland, Ohio 44106, USA. gxk6@po.cwru.edu","1Department of Chemistry, Case Western Reserve University, Cleveland, Ohio 44106 (G.K., L.M.S.), and #N#        2Cancer Center for Hematology, Texas Children\u2019s Hospital, M/C3 3320, Houston, Texas 77030 (A.R.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Case Western Reserve University, Cleveland, Ohio 44106, USA. gxk6@po.cwru.edu","institution_ids":["https://openalex.org/I58956616"]},{"raw_affiliation_string":"1Department of Chemistry, Case Western Reserve University, Cleveland, Ohio 44106 (G.K., L.M.S.), and #N#        2Cancer Center for Hematology, Texas Children\u2019s Hospital, M/C3 3320, Houston, Texas 77030 (A.R.)","institution_ids":["https://openalex.org/I4210147586","https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041312244","display_name":"Leming M. Shi","orcid":"https://orcid.org/0000-0002-2981-4150","observed_orcids":["https://orcid.org/0000-0002-2981-4150"]},"institutions":[{"id":"https://openalex.org/I4210147586","display_name":"Texas Children's Hospital","ror":"https://ror.org/05cz92x43","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210147586"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leming M. Shi","raw_affiliation_strings":["1Department of Chemistry, Case Western Reserve University, Cleveland, Ohio 44106 (G.K., L.M.S.), and \n        2Cancer Center for Hematology, Texas Children\u2019s Hospital, M/C3 3320, Houston, Texas 77030 (A.R.)","1Department of Chemistry, Case Western Reserve University, Cleveland, Ohio 44106 (G.K., L.M.S.), and #N#        2Cancer Center for Hematology, Texas Children\u2019s Hospital, M/C3 3320, Houston, Texas 77030 (A.R.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Chemistry, Case Western Reserve University, Cleveland, Ohio 44106 (G.K., L.M.S.), and \n        2Cancer Center for Hematology, Texas Children\u2019s Hospital, M/C3 3320, Houston, Texas 77030 (A.R.)","institution_ids":["https://openalex.org/I4210147586","https://openalex.org/I58956616"]},{"raw_affiliation_string":"1Department of Chemistry, Case Western Reserve University, Cleveland, Ohio 44106 (G.K., L.M.S.), and #N#        2Cancer Center for Hematology, Texas Children\u2019s Hospital, M/C3 3320, Houston, Texas 77030 (A.R.)","institution_ids":["https://openalex.org/I4210147586","https://openalex.org/I58956616"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111798444","display_name":"Avner Ramu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147586","display_name":"Texas Children's Hospital","ror":"https://ror.org/05cz92x43","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210147586"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Avner Ramu","raw_affiliation_strings":["1Department of Chemistry, Case Western Reserve University, Cleveland, Ohio 44106 (G.K., L.M.S.), and \n        2Cancer Center for Hematology, Texas Children\u2019s Hospital, M/C3 3320, Houston, Texas 77030 (A.R.)","1Department of Chemistry, Case Western Reserve University, Cleveland, Ohio 44106 (G.K., L.M.S.), and #N#        2Cancer Center for Hematology, Texas Children\u2019s Hospital, M/C3 3320, Houston, Texas 77030 (A.R.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Chemistry, Case Western Reserve University, Cleveland, Ohio 44106 (G.K., L.M.S.), and \n        2Cancer Center for Hematology, Texas Children\u2019s Hospital, M/C3 3320, Houston, Texas 77030 (A.R.)","institution_ids":["https://openalex.org/I4210147586","https://openalex.org/I58956616"]},{"raw_affiliation_string":"1Department of Chemistry, Case Western Reserve University, Cleveland, Ohio 44106 (G.K., L.M.S.), and #N#        2Cancer Center for Hematology, Texas Children\u2019s Hospital, M/C3 3320, Houston, Texas 77030 (A.R.)","institution_ids":["https://openalex.org/I4210147586","https://openalex.org/I58956616"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3600,"currency":"USD","value_usd":3600},"apc_paid":null,"fwci":2.6965,"has_fulltext":false,"cited_by_count":151,"citation_normalized_percentile":{"value":0.909689,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"52","issue":"2","first_page":"323","last_page":"334"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.8384000062942505,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.8384000062942505,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.15760000050067902,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.9319999814033508},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.8650000095367432},{"id":"https://openalex.org/keywords/paclitaxel-resistance","display_name":"paclitaxel resistance","score":0.7839999794960022},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.7129999995231628},{"id":"https://openalex.org/keywords/quaternary-ammonium-salts","display_name":"quaternary ammonium compounds","score":0.8360000252723694},{"id":"https://openalex.org/keywords/partition-coefficient","display_name":"partition coefficient","score":0.8029999732971191},{"id":"https://openalex.org/keywords/graph-indices","display_name":"graph index","score":0.9610000252723694},{"id":"https://openalex.org/keywords/rational-drug-design","display_name":"rational drug design","score":0.7289999723434448},{"id":"https://openalex.org/keywords/anticancer-drug-design","display_name":"anticancer drug design","score":0.6039999723434448}],"concepts":[{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.6541882753372192},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.49048396944999695},{"id":"https://openalex.org/C2983288658","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Cancer chemotherapy","level":3,"score":0.48031941056251526},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4774092435836792},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.47341424226760864},{"id":"https://openalex.org/C192552737","wikidata":"https://www.wikidata.org/wiki/Q898797","display_name":"Partition coefficient","level":2,"score":0.4677833318710327},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4638856053352356},{"id":"https://openalex.org/C164126121","wikidata":"https://www.wikidata.org/wiki/Q766383","display_name":"Quantitative structure\u2013activity relationship","level":2,"score":0.4484984576702118},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.44731009006500244},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.4458525478839874},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.4451177716255188},{"id":"https://openalex.org/C53105671","wikidata":"https://www.wikidata.org/wiki/Q14777816","display_name":"Rational design","level":2,"score":0.41079598665237427},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.346660315990448},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.29556161165237427},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2832881510257721},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.26449617743492126},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.24827444553375244},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.12113887071609497},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09898754954338074},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D018432","descriptor_name":"Drug Resistance, Multiple","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1124/mol.52.2.323","doi":"https://doi.org/10.1124/mol.52.2.323","is_oa":false,"landing_page_url":"https://doi.org/10.1124/mol.52.2.323","pdf_url":null,"source":{"id":"https://openalex.org/S62949411","display_name":"Molecular Pharmacology","issn_l":"0026-895X","issn":["0026-895X","1521-0111"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmacology","raw_type":"journal-article"},{"id":"pmid:9271356","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9271356","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":61,"referenced_works":["https://openalex.org/W27600685","https://openalex.org/W175263069","https://openalex.org/W1541258411","https://openalex.org/W1551959442","https://openalex.org/W1554758928","https://openalex.org/W1569118791","https://openalex.org/W1571215201","https://openalex.org/W1581796999","https://openalex.org/W1588153252","https://openalex.org/W1602443281","https://openalex.org/W1605234039","https://openalex.org/W1769138064","https://openalex.org/W1909878947","https://openalex.org/W1915172695","https://openalex.org/W1925657344","https://openalex.org/W1966785965","https://openalex.org/W1984620227","https://openalex.org/W1985953075","https://openalex.org/W1986866456","https://openalex.org/W1996878563","https://openalex.org/W2000375621","https://openalex.org/W2002808451","https://openalex.org/W2008764714","https://openalex.org/W2012719422","https://openalex.org/W2012845533","https://openalex.org/W2017761850","https://openalex.org/W2022776591","https://openalex.org/W2027690665","https://openalex.org/W2028533496","https://openalex.org/W2034486771","https://openalex.org/W2040122797","https://openalex.org/W2054549443","https://openalex.org/W2066968597","https://openalex.org/W2070038334","https://openalex.org/W2077314516","https://openalex.org/W2082437291","https://openalex.org/W2084088795","https://openalex.org/W2084905360","https://openalex.org/W2097836532","https://openalex.org/W2098426299","https://openalex.org/W2107132176","https://openalex.org/W2110936276","https://openalex.org/W2118234018","https://openalex.org/W2138691689","https://openalex.org/W2153712534","https://openalex.org/W2166303310","https://openalex.org/W2170846620","https://openalex.org/W2188740730","https://openalex.org/W2277869106","https://openalex.org/W2337432642","https://openalex.org/W2338066846","https://openalex.org/W2346906340","https://openalex.org/W2409644790","https://openalex.org/W2412192011","https://openalex.org/W2414445193","https://openalex.org/W2415990034","https://openalex.org/W2467761676","https://openalex.org/W2949702410","https://openalex.org/W6633102678","https://openalex.org/W6634942204","https://openalex.org/W6676378755"],"related_works":["https://openalex.org/W2045973642","https://openalex.org/W2171528706","https://openalex.org/W2373757984","https://openalex.org/W2044442595","https://openalex.org/W1769138064","https://openalex.org/W2082016236","https://openalex.org/W2804333856","https://openalex.org/W2066968597","https://openalex.org/W2071547598","https://openalex.org/W2315439340"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2139353173","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
